MX2014012569A - Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof. - Google Patents
Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof.Info
- Publication number
- MX2014012569A MX2014012569A MX2014012569A MX2014012569A MX2014012569A MX 2014012569 A MX2014012569 A MX 2014012569A MX 2014012569 A MX2014012569 A MX 2014012569A MX 2014012569 A MX2014012569 A MX 2014012569A MX 2014012569 A MX2014012569 A MX 2014012569A
- Authority
- MX
- Mexico
- Prior art keywords
- strains
- lactobacillus brevis
- isolation
- bile salt
- selection
- Prior art date
Links
- 240000001929 Lactobacillus brevis Species 0.000 title abstract 4
- 235000013957 Lactobacillus brevis Nutrition 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 3
- 108010000231 Choloylglycine hydrolase Proteins 0.000 title abstract 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 240000004246 Agave americana Species 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 240000006617 Agave salmiana Species 0.000 abstract 1
- 235000001619 Agave salmiana Nutrition 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to strains of Lactobacillus brevis, LbH2, LbH3, LbH5, LbH9 and LbH13, isolated from the juice of Agave salmiana and the method for the isolation thereof, wherein said strains have bile salt hydrolase (SBH) activity as well as probiotic properties that help to prevent an increase in total cholesterol. The invention also relates to a mixture of strains of Lactobacillus brevis, also known as Lactobacillus brevis mix, which prevents damage to the liver since it reduces the activity of the serum enzymes, markers of liver damage.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014012569A MX2014012569A (en) | 2014-10-17 | 2014-10-17 | Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof. |
| PCT/MX2015/000136 WO2016060539A1 (en) | 2014-10-17 | 2015-10-15 | Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2014012569A MX2014012569A (en) | 2014-10-17 | 2014-10-17 | Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014012569A true MX2014012569A (en) | 2016-04-18 |
Family
ID=55746981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014012569A MX2014012569A (en) | 2014-10-17 | 2014-10-17 | Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof. |
Country Status (2)
| Country | Link |
|---|---|
| MX (1) | MX2014012569A (en) |
| WO (1) | WO2016060539A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109182191B (en) * | 2018-09-26 | 2021-08-17 | 富乐顿生物工程科技（北京）有限公司 | Space lactobacillus plantarum FH-SS 18-86365L with liver protection effect and application thereof |
| CN111944712B (en) * | 2020-07-13 | 2022-05-10 | 天津科技大学 | Lactobacillus plantarum with excellent alcohol tolerance and application thereof |
| CN114717150B (en) * | 2022-04-20 | 2023-01-17 | 河北农业大学 | Lactobacillus plantarum CRS33 and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2711532C (en) * | 2008-01-15 | 2014-04-08 | Sapporo Breweries Limited | Agent for prevention of alcoholic hepatopathy |
-
2014
- 2014-10-17 MX MX2014012569A patent/MX2014012569A/en unknown
-
2015
- 2015-10-15 WO PCT/MX2015/000136 patent/WO2016060539A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016060539A1 (en) | 2016-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018014890A (en) | Cleaning compositions comprising enzymes. | |
| MX2023001189A (en) | Cell-free production of ribonucleic acid. | |
| MX2018006239A (en) | Compositions comprising bacterial strains. | |
| MX2017016398A (en) | Compositions comprising bacterial strains. | |
| EP4219532A3 (en) | Compositions and methods for transient gene therapy with enhanced stability | |
| MX2016013668A (en) | Irak inhibitors and uses thereof. | |
| NZ727481A (en) | Methods and compositions for modifying a targeted locus | |
| PH12020550833A1 (en) | Rnai constructs for inhibiting pnpla3 expression | |
| MX2016014235A (en) | Microbial ergothioneine biosynthesis. | |
| MX2017009937A (en) | Fungal strains and methods of use. | |
| MX2021014663A (en) | Compound targeting il-23a and tnf-alpha and uses thereof. | |
| MX2021006732A (en) | Beverage nanoemulstions produced by high shear processing. | |
| MX2017005342A (en) | Enzymes for malting. | |
| MY189867A (en) | Solubilization of msw with blend enzymes | |
| MX2014000984A (en) | Biocontrol of nematodes. | |
| RS20150134A1 (en) | Panel interconnectable with similar panels for forming a covering | |
| MX2017012665A (en) | Cell-free production of ribonucleic acid. | |
| MA40460A (en) | Lysosomal targeting and uses thereof | |
| WO2014066903A8 (en) | Biocontrol of nematodes | |
| MX2014012569A (en) | Strains of lactobacillus brevis isolated from agave juice with bile salt hydrolase activity, and method for the isolation and selection thereof. | |
| WO2014097318A3 (en) | Agents for eliminating tumour-initiating cells | |
| MX2018016037A (en) | Lipase variants and compositions comprising surfactant and lipase variant. | |
| MX2017014890A (en) | Aldc production methods. | |
| EP3225256A4 (en) | Disintegrative particle composition including pulverized lactose or granulated lactose | |
| CA2940322C (en) | De novo design of allosteric proteins |